FDA Enforcement Class II Terminated

Neurosign 100, Product Number 9883-01. Intraoperative Nerve Monitor - Product Usage: indicated for use in stimulating and monitoring cranial motor nerves, especially the facial nerve (VII), during ENT surgical procedures.

Recall: Z-0869-2021 · Reported January 27, 2021

Enforcement

Recall Number
Z-0869-2021
Event ID
87063
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
The Magstim Company Limited
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
E-Mail
Report Date
January 27, 2021
Initiation Date
December 8, 2020
Classification Date
January 15, 2021
Termination Date
February 16, 2023
Address
Spring Gardens, N/A, Whitland, N/A, N/A, United Kingdom

Description

Neurosign 100, Product Number 9883-01. Intraoperative Nerve Monitor - Product Usage: indicated for use in stimulating and monitoring cranial motor nerves, especially the facial nerve (VII), during ENT surgical procedures.

Reason

A small number of Neurosign 100 Intraoperative Nerve Monitors may have been dispatched without being configured appropriately for the supply mains within the target Country. The specific deficiency includes: 1. Onboard voltage selector set to 240V (European Standard), versus 120V requirement for the United States and Canada. 2. Fuses installed in the Power Entry Module (PEM) 2xT315mAL (240V Standard), versus the 2xT630mAL requirement for a 120V mains supply.

Code Info

Serial Numbers: 2507, 2511, 2514, 2515, 2522, 2527, 2533, 2534, 2537

Distribution

MN, NC, and NY

Quantity

7 units